Negative-positive pressurizable implant

US9351834B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9351834-B2
Application numberUS-201213608155-A
CountryUS
Kind codeB2
Filing dateSep 10, 2012
Priority dateSep 12, 2011
Publication dateMay 31, 2016
Grant dateMay 31, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A pressurizable implant, comprising a cylindrical body and at least one porous arm extending from and interconnected to the cylindrical body, the at least one porous arm being configured to accommodate a pressure gradient that is created by a device removably connectable to the cylindrical body.

First claim

Opening claim text (preview).

What is claimed is: 1. A pressurizable implant, comprising: a body shaped as a cylinder and defining a longitudinal axis; and a plurality of porous arms extending from and interconnected to the body at a single location along the longitudinal axis, the plurality of porous arms being configured to accommodate a pressure gradient that is created by a device removably connectable to the body, wherein at least one of the plurality of porous arms includes a biological surface coating disposed upon a surface thereof, the biological surface coating configured to promote the fixation of the pressurizable implant through enhancement of bony ingrowth. 2. The pressurizable implant of claim 1 , wherein at least one of the plurality of porous arms is interconnected to the body via a channel or duct. 3. The pressurizable implant of claim 1 , wherein the body includes an internal chamber that is configured to removably house an airtight seal. 4. The pressurizable implant of claim 3 , wherein at least one of the plurality of porous arms is configured to accommodate a negative pressure gradient as a result of the device removing air through the airtight seal. 5. The pressurizable implant of claim 3 , wherein at least one of the plurality of porous arms is configured to accommodate a positive pressure gradient as a result of the device delivering a pharmacological agent through the airtight seal, the pharmacological agent being selected from at least one of medicines, antibiotics, growth factors and blood platelets. 6. The pressurizable implant of claim 1 , wherein the body is metallic. 7. The pressurizable implant of claim 1 , wherein the device is a syringe. 8. A system for pressurizing an implant, comprising: a body shaped as a cylinder and defining a longitudinal axis, the body having an internal chamber; a plurality of porous arms extending from the body at a single location along the longitudinal axis, each of the plurality of porous arms being interconnected to the internal chamber via a channel or duct, wherein at least one of the plurality of porous arms includes a biological surface coating disposed upon a surface thereof, the biological surface coating configured to promote the fixation of the pressurizable implant through enhancement of bony ingrowth; an airtight seal; and a device configured to removably couple to the airtight seal to distribute a pressure gradient across the at least one porous arm. 9. The pressurizable implant system of claim 8 , wherein the device is configured to distribute a negative pressure gradient across at least one of the plurality of porous arms as a result of the device removing air through the airtight seal. 10. The pressurizable implant system of claim 9 , wherein the device is a syringe. 11. The pressurizable implant system of claim 8 , wherein at least one of the plurality of porous arms is configured to accommodate a positive pressure gradient as a result of the device delivering a pharmacological agent through the airtight seal, the pharmacological agent being selected from at least one of medicines, antibiotics, growth factors and blood platelets. 12. The pressurizable implant system of claim 11 , wherein the device is a syringe. 13. The pressurizable implant system of claim 8 , wherein the body is metallic. 14. A pressurizable implant, comprising: a body shaped as a cylinder and defining a longitudinal axis, the body including an outer surface and an inner surface defining an internal chamber; and a plurality of arms interconnected to the body at a single location along the longitudinal axis, each of the plurality of arms: in contact with the outer surface of the body, extending externally of the internal chamber and away from the outer surface, and configured to accommodate a pressure gradient that is created by a device removably connectable to the body. 15. The pressurizable implant of claim 14 , wherein the at least one arm includes a plurality of arms arranged around and in contact with the outer surface of the body. 16. The pressurizable implant of claim 15 , wherein the body includes one or more channels, wherein each of the plurality of arms is coupled to one of the one or more channels. 17. The pressurizable implant of claim 16 , wherein each of the plurality of arms includes a duct, wherein each of the ducts is operatively connected to the internal chamber through the one or more channels. 18. The pressurizable implant of claim 16 , wherein each of the plurality of arms includes a biological surface coating disposed upon a surface thereof, the biological surface coating configured to promote the fixation of the pressurizable implant through enhancement of bony ingrowth.

Assignees

Inventors

Classifications

  • having an open-celled or open-pored structure · CPC title

  • the pharmaceutical product being in a reservoir · CPC title

  • Drainage means, e.g. for evacuating blood or other fluids · CPC title

  • made from both porous and non-porous parts, e.g. adjacent parts · CPC title

  • the pharmaceutical product being in a reservoir · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9351834B2 cover?
A pressurizable implant, comprising a cylindrical body and at least one porous arm extending from and interconnected to the cylindrical body, the at least one porous arm being configured to accommodate a pressure gradient that is created by a device removably connectable to the cylindrical body.
Who is the assignee on this patent?
Mcdaniel John M, Winslow Nathan, Biomet Mfg Llc
What technology area does this patent fall under?
Primary CPC classification A61F2/4014. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).